We report the cloning and functional analysis of a third member of the
CDR gene family in Candida albicans, named CDR3. This gene codes for
an ABC (ATP-binding cassette) transporter of 1,501 amino acids highly
homologous to Cdr1p and Cdr2p (56 and 55% amino acid sequence identity
, respectively), two transporters involved in fluconazole resistance i
n C. albicans. The predicted structure of Cdr3p is typical of the PDR/
CDR family, with two similar halves, each comprising an N-terminal hyd
rophilic domain with consensus sequences for ATP binding and a C-termi
nal hydrophobic domain with six predicted transmembrane segments. Nort
hern analysis showed that CDR3 expression is regulated, in a cell-type
-specific manner, with low levels of CDR3 mRNA in CAI4 yeast and hypha
l cells, high levels in WO-1 opaque sells, and undetectable levels in
WO-1 white cells. Disruption of both alleles of CDR3 in CAI4 resulted
in no obvious changes in cell morphology, growth rate, or susceptibili
ty to fluconazole. Overexpression of Cdr3p in C. albicans did not resu
lt in increased cellular resistance to fluconazole, cycloheximide, and
4-nitroquinoline-N-oxide, which are known substrates for different tr
ansporters of the PDR/CDR family. These results indicate that despite
a high degree of sequence conservation with C. albicans Cdr1p and Cdr2
p, Cdr3p does not appear to be involved in drug resistance, at least t
o the compounds tested which include the clinically relevant antifunga
l agent fluconazole. Rather, the high level of Cdr3p expression in WO-
1 opaque cells suggests an opaque-phase-associated biological function
which remains to be identified.